Post AIDS 2022 Webinar:  Expert Panel Discussion of 2022 AIDS ViiV-Sponsored Data

POST AIDS 2022 Webinar

Expert Panel Discussion of 2022 AIDS ViiV-Sponsored Data

Expert discussions recorded during AIDS 2022 in Montreal, Canada

Utilizing and Applying Findings from Observational Studies in AIDS Research

Shelly Dhir, PharmD Sr. Director, Portfolio Medical Lead
Dr. Rick Elion, MD Director of Clinical Research, Washington Health Institute and Clinical Professor of Medicine George Washington University School of Medicine

Using Fewer HIV Treatments When Treating HIV Long Term

Andrew Zolopa, MD VP, Head, North American Medical Affairs ViiV Healthcare
Dr. Babafemi Taiwo, MD, MBBS Gene Stollerman Professor of Medicine and Chief of the Division of Infectious Diseases Northwestern University

Discussing CABENUVA Data at AIDS 2022

Bruce Gilliam, MD, FACP Sr. Medical Director, North American Medical Affairs
Dr. Moti Ramgopal, MD, FIDSA, FACP Associate Professor of Medicine Medical Director Midway Research Center and Found of Midway Specialty Care Centers

Discussing the BRIGHTE Study at AIDS 2022

Bruce Gilliam, MD, FACP Sr. Medical Director, North American Medical Affairs
Dr. Moti Ramgopal, MD, FIDSA, FACP Associate Professor of Medicine Medical Director Midway Research Center and Found of Midway Specialty Care Centers

Are you a US healthcare provider?

This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.

If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.

Connect With Our Medical Experts

Find My ViiV MSL

Easily find the ViiV Medical Science Liaison (MSL) in your area.

Request a Scientific Discussion

Submit a request for additional information from a ViiV Medical Expert.

Contact Us

Chat Live

Get immediate assistance from a ViiV Healthcare Professional.

Call 1‑888‑226‑8434

Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)

Report an Adverse Event

To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1‑877‑844‑8872 or FDA at 1‑800‑332‑1088 or www.fda.gov/medwatch